Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis
- PMID: 31608438
- DOI: 10.1111/epi.16366
Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis
Abstract
Objective: To estimate the comparative efficacy and safety of antiepileptic drugs (AEDs) in the elderly with new-onset epilepsy.
Methods: We searched electronic databases for randomized controlled trials (RCTs) of monotherapy AEDs to treat epilepsy in elderly. The following outcomes were analyzed: seizure freedom and withdrawal from the study for any cause at 6 and 12 months; withdrawal from the study for any adverse event (AE) at 12 months; and occurrence of any AE at 12 months. Effect sizes were estimated by network meta-analyses within a frequentist framework. The hierarchy of competing interventions was established using the surface under the cumulative ranking curve (SUCRA) and mean ranks.
Results: Five RCTs (1425 patients) were included. Included AEDs were carbamazepine immediate- and controlled-release (CBZ-IR, CBZ-CR), gabapentin (GBP), lacosamide (LCM), lamotrigine (LTG), levetiracetam (LEV), phenytoin (PHT), and valproic acid (VPA). At the pairwise and network meta-analyses, there were no differences in any of the comparison according to 6- and 12-month seizure freedom. The treatment with CBZ-IR and CBZ-CR was associated with a higher risk of withdrawal than LTG, LEV, or VPA, and CBZ-IR had the overall highest probability of discontinuation across all AEDs. According to SUCRA, the following had the greatest likelihood ranking best for seizure freedom at 6 and 12 months: LCM, LTG, and LEV. CBZ-CR and CBZ-IR had the highest probabilities of being worst for the 12-month retention. CBZ-IR, CBZ-CR, and GBP had the highest probabilities of withdrawal from the study for AEs, , and VPA had the highest probability of being the best-tolerated option.
Significance: Although no significant difference in efficacy was found across treatments, LCM, LTG, and LEV had the highest probability of ranking best for achieving seizure freedom. CBZ-IR and CBZ-CR showed a poor tolerability profile, leading to higher withdrawal rates compared to LEV and VPA.
Keywords: elderly; epilepsy; monotherapy; network meta-analysis; randomized-controlled trials.
Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.
Similar articles
-
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.BMC Neurol. 2016 Aug 23;16(1):149. doi: 10.1186/s12883-016-0663-7. BMC Neurol. 2016. PMID: 27552848 Free PMC article. Clinical Trial.
-
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29. J Neurol Neurosurg Psychiatry. 2013. PMID: 22933814 Clinical Trial.
-
A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.Epilepsia. 2015 Mar;56(3):450-9. doi: 10.1111/epi.12926. Epub 2015 Feb 12. Epilepsia. 2015. PMID: 25684224 Clinical Trial.
-
Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis.Epilepsy Behav. 2019 Dec;101(Pt B):106466. doi: 10.1016/j.yebeh.2019.106466. Epub 2019 Aug 25. Epilepsy Behav. 2019. PMID: 31462385
-
Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis.CNS Drugs. 2023 Oct;37(10):883-913. doi: 10.1007/s40263-023-01029-0. Epub 2023 Aug 17. CNS Drugs. 2023. PMID: 37589821
Cited by
-
Treatment Outcome and Risk Factors of Adult Newly Diagnosed Epilepsy: A Prospective Hospital-Based Study in Northeast China.Front Neurol. 2021 Oct 28;12:747958. doi: 10.3389/fneur.2021.747958. eCollection 2021. Front Neurol. 2021. PMID: 34777218 Free PMC article.
-
Acute symptomatic seizures and status epilepticus in older adults: A narrative review focusing on management and outcomes.Front Neurol. 2022 Aug 26;13:954986. doi: 10.3389/fneur.2022.954986. eCollection 2022. Front Neurol. 2022. PMID: 36090864 Free PMC article. Review.
-
Demographics, Clinical Characteristics, and Management Strategies of Epilepsy in Saudi Arabia: A Systematic Review.Cureus. 2024 Jun 29;16(6):e63436. doi: 10.7759/cureus.63436. eCollection 2024 Jun. Cureus. 2024. PMID: 39077233 Free PMC article. Review.
-
Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy.Front Neurol. 2022 Nov 10;13:1042168. doi: 10.3389/fneur.2022.1042168. eCollection 2022. Front Neurol. 2022. PMID: 36438960 Free PMC article.
-
Challenges and prospects in geriatric epilepsy treatment: the role of the blood-brain barrier in pharmacotherapy and drug delivery.Front Aging Neurosci. 2024 Feb 8;16:1342366. doi: 10.3389/fnagi.2024.1342366. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38389560 Free PMC article. Review.
References
REFERENCES
-
- Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34:453-68.
-
- Sillanpää M, Gissler M, Schmidt D. Efforts in epilepsy prevention in the last 40 years: lessons from a large nationwide study. JAMA Neurol. 2016;73:390-5.
-
- Liu S, Yu W, Lu Y. The causes of new-onset epilepsy and seizures in the elderly. Neuropsychiatr Dis Treat. 2016;12:1425-34.
-
- Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res. 2006;68(Suppl 1):S39-48.
-
- Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol Scand Suppl. 2003;180:33-6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials